IBT
ORIC icon

International Biotechnology Trust’s Oric Pharmaceuticals ORIC Stock Holding History

International Biotechnology Trust’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-176,217
Closed -$905K – 80
2022
Q1 		$905K Buy
176,217
+23,217
+15% +$209K 0.2% 56
2021
Q4 		$2.25M Buy
153,000
+100,000
+189% +$1.56M 0.5% 42
2021
Q3 		$1.1M Hold
53,000
– – 0.27% 53
2021
Q2 		$938K Hold
53,000
– – 0.25% 53
2021
Q1 		$1.3M Hold
53,000
– – 0.34% 44
2020
Q4 		$1.79M Buy
+53,000
New +$1.52M 0.49% 36

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return